© Reuters.
FMC Corporation (NYSE:), a global agricultural sciences company, is facing a securities fraud class action lawsuit. The suit was filed on Thursday, November 9, 2023, by Berger Montague, represented by James Maro and Andrew Abramowitz, on behalf of investors who bought common stock between November 2, 2022 and October 20, 2023. The lawsuit alleges that FMC relied on misleading information about patent protection and generic competition.
Earlier on the same day, PRNewswire reported about the lawsuit representing shareholders who purchased FMC’s shares during the “Class Period” from November 2, 2022 to October 20, 2023. The news about the legal proceedings and FMC’s status was sourced from Barchart Market Data Solutions, Morningstar, Zacks Investment Research, and Edgar Online.
The lawsuit claims that FMC failed to disclose increased competition from generics due to diminished patent protection and misled investors about these proceedings. The lead plaintiff is being sought until January 8, 2024.
This legal action follows a series of events that negatively impacted FMC’s stock price. On October 23, 2023, FMC announced another cut in its Q3 outlook and guidance for Q4 and fiscal year 2024 revenues due to lower sales volumes in Latin America. This announcement caused an $8.83 per share or a 12.18% drop in its stock price.
Previously on September 7, 2023, Blue Orca Capital reported that FMC made false statements about its patent protections after legal defeats in key markets such as India, China, and Brazil. This report led to a $6.09 per share or over a 7.4% decrease in FMC’s stock price.
Additionally, on July 10, 2023, FMC reduced its Q2 and fiscal year 2023 revenue projections due to lower-than-expected sales volumes in North America, Latin America, and EMEA. This resulted in an $11.62 per share or an 11.14% drop in its stock price.
The lawsuit’s outcome is yet to be determined and it is unclear what impact this will have on FMC’s future operations and stock performance. It’s important for investors to stay informed about the progress of this case. FMC, a firm heavily dependent on patent protections for its crop protection products, allegedly misled investors with optimistic projections while concealing legal losses in key markets throughout 2023.
InvestingPro Insights
InvestingPro’s real-time data and expert analysis offer a deeper understanding of FMC Corporation’s current situation. According to InvestingPro, FMC operates with a significant debt burden and poor earnings and cash flow, which may force dividend cuts (InvestingPro Tips 0 and 3). However, it’s worth noting that the company has maintained dividend payments for 18 consecutive years and has raised its dividend for 5 consecutive years (InvestingPro Tips 4 and 11).
InvestingPro’s data indicates that FMC’s Market Cap stands at 6250M USD, with a P/E Ratio of 12.64 and a PEG Ratio of -0.48 as of Q3 2023. In the same period, the company’s revenue was 4962.7M USD, reflecting a decrease of 11.28% (InvestingPro Data).
InvestingPro offers many more tips and data points that can help investors make informed decisions. The current situation with FMC, coupled with the insights from InvestingPro, underscores the importance of thorough research and analysis in investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here